-
Forward Look
Treating Brain MetastasesNeurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
by Kendall K. Morgan
-
Forward Look
Many Online Pharmacies Are IllegitimatePatients looking for online discounts for drugs should proceed with caution.
by Eric Fitzsimmons
-
Forward Look
Losing HeartCardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
by Marci A. Landsmann
-
Forward Look
Cancer Clinical Trials May Get a Boost From TelehealthRemote approaches would remove barriers, potentially improving patient participation and diversity.
by Stephen Ornes
-
Mysterious Microbes
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
by Natalie Slivinski
-
Healthy Habits
Vital VeggiesAllium vegetables, such as garlic and onions, contain a compound that may lower the risk for several cancers.
by Erin O'Donnell
-
Capivasertib Extends Progression-Free Survival in Hormone Receptor-Positive Breast Cancer
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
by Eric Fitzsimmons
-
Pregnancy After a Breast Cancer Diagnosis
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
by Thomas Celona
-
Disparities in Breast Cancer Outcomes for Black Women Despite Similar Recurrence Scores
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
by Eric Fitzsimmons
-
A ‘Revolution’ in Cancer Research
AACR patient advocate forum explores how new clinical trial designs are accelerating drug testing.
by Thomas Celona
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff